Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 158 entries
Sorted by: Best Match Show Resources per page
[Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006;34:233-8].

Gynecologie, obstetrique & fertilite

Raudrant D, Golfier F.
PMID: 16807044
Gynecol Obstet Fertil. 2006 Jul-Aug;34(7):670. doi: 10.1016/j.gyobfe.2006.06.002. Epub 2006 Jun 30.

No abstract available.

Cite
Raudrant D, Golfier F. Place de la chirurgie dans la prise en charge des tumeurs trophoblastiques gestationnelles. Gynecol Obstet Fertil 2006;34:233-8. [Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006;34:233-8]. Gynecol Obstet Fertil. 2006;34(7):670doi: 10.1016/j.gyobfe.2006.06.002.
Raudrant, D., & Golfier, F. (2006). Place de la chirurgie dans la prise en charge des tumeurs trophoblastiques gestationnelles. Gynecol Obstet Fertil 2006;34:233-8. [Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006;34:233-8]. Gynecologie, obstetrique & fertilite, 34(7), 670. https://doi.org/10.1016/j.gyobfe.2006.06.002
Raudrant, D, and Golfier, F. "Place de la chirurgie dans la prise en charge des tumeurs trophoblastiques gestationnelles. Gynecol Obstet Fertil 2006;34:233-8." [Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006;34:233-8]. Gynecologie, obstetrique & fertilite vol. 34,7 (2006): 670. doi: https://doi.org/10.1016/j.gyobfe.2006.06.002
Raudrant D, Golfier F. Place de la chirurgie dans la prise en charge des tumeurs trophoblastiques gestationnelles. Gynecol Obstet Fertil 2006;34:233-8. [Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006;34:233-8]. Gynecol Obstet Fertil. 2006 Jul-Aug;34(7):670. doi: 10.1016/j.gyobfe.2006.06.002. Epub 2006 Jun 30. French. PMID: 16807044.
Copy Download .nbib Format: NLM
[Definition of endometriosis expert centres].

Gynecologie, obstetrique, fertilite & senologie

Chanavaz-Lacheray I, Darai E, Descamps P, Agostini A, Poilblanc M, Rousset P, Bolze PA, Panel P, Collinet P, Hebert T, Graesslin O, Martigny H, Brun JL, Dechaud H, Mezan De Malartic C, Piechon L, Wattiez A, Chapron C, Golfier F.
PMID: 29490889
Gynecol Obstet Fertil Senol. 2018 Mar;46(3):376-382. doi: 10.1016/j.gofs.2018.01.009. Epub 2018 Feb 25.

OBJECTIVES: The Collège national des gynécologues obstétriciens français (CNGOF), in agreement with the Société de chirurgie gynécologique et pelvienne (SCGP), has set up a commission in 2017 to define endometriosis expert centres, with the aim of optimizing endometriosis care...

Cite
Chanavaz-Lacheray I, Darai E, Descamps P, et al. Définition des centres experts en endométriose. [Definition of endometriosis expert centres]. Gynecol Obstet Fertil Senol. 2018;46(3):376-382doi: 10.1016/j.gofs.2018.01.009.
Chanavaz-Lacheray, I., Darai, E., Descamps, P., Agostini, A., Poilblanc, M., Rousset, P., Bolze, P. A., Panel, P., Collinet, P., Hebert, T., Graesslin, O., Martigny, H., Brun, J. L., Dechaud, H., Mezan De Malartic, C., Piechon, L., Wattiez, A., Chapron, C., & Golfier, F. (2018). Définition des centres experts en endométriose. [Definition of endometriosis expert centres]. Gynecologie, obstetrique, fertilite & senologie, 46(3), 376-382. https://doi.org/10.1016/j.gofs.2018.01.009
Chanavaz-Lacheray, I, et al. "Définition des centres experts en endométriose." [Definition of endometriosis expert centres]. Gynecologie, obstetrique, fertilite & senologie vol. 46,3 (2018): 376-382. doi: https://doi.org/10.1016/j.gofs.2018.01.009
Chanavaz-Lacheray I, Darai E, Descamps P, Agostini A, Poilblanc M, Rousset P, Bolze PA, Panel P, Collinet P, Hebert T, Graesslin O, Martigny H, Brun JL, Dechaud H, Mezan De Malartic C, Piechon L, Wattiez A, Chapron C, Golfier F. Définition des centres experts en endométriose. [Definition of endometriosis expert centres]. Gynecol Obstet Fertil Senol. 2018 Mar;46(3):376-382. doi: 10.1016/j.gofs.2018.01.009. Epub 2018 Feb 25. French. PMID: 29490889.
Copy Download .nbib Format: NLM
The definition of Endometriosis Expert Centres.

Journal of gynecology obstetrics and human reproduction

Golfier F, Chanavaz-Lacheray I, Descamps P, Agostini A, Poilblanc M, Rousset P, Bolze PA, Panel P, Collinet P, Hebert T, Graesslin O, Martigny H, Brun JL, Déchaud H, de Malartic CM, Piechon L, Wattiez A, Chapron C, Daraï E.
PMID: 29510272
J Gynecol Obstet Hum Reprod. 2018 May;47(5):179-181. doi: 10.1016/j.jogoh.2018.02.003. Epub 2018 Mar 03.

Endometriosis is a common condition that causes pain and infertility. It can lead to absenteeism and also to multiple surgeries with a consequent risk of impaired fertility, and constitutes a major public health cost. Despite the existence of numerous...

Cite
Golfier F, Chanavaz-Lacheray I, Descamps P, et al. The definition of Endometriosis Expert Centres. J Gynecol Obstet Hum Reprod. 2018;47(5):179-181doi: 10.1016/j.jogoh.2018.02.003.
Golfier, F., Chanavaz-Lacheray, I., Descamps, P., Agostini, A., Poilblanc, M., Rousset, P., Bolze, P. A., Panel, P., Collinet, P., Hebert, T., Graesslin, O., Martigny, H., Brun, J. L., Déchaud, H., de Malartic, C. M., Piechon, L., Wattiez, A., Chapron, C., & Daraï, E. (2018). The definition of Endometriosis Expert Centres. Journal of gynecology obstetrics and human reproduction, 47(5), 179-181. https://doi.org/10.1016/j.jogoh.2018.02.003
Golfier, F, et al. "The definition of Endometriosis Expert Centres." Journal of gynecology obstetrics and human reproduction vol. 47,5 (2018): 179-181. doi: https://doi.org/10.1016/j.jogoh.2018.02.003
Golfier F, Chanavaz-Lacheray I, Descamps P, Agostini A, Poilblanc M, Rousset P, Bolze PA, Panel P, Collinet P, Hebert T, Graesslin O, Martigny H, Brun JL, Déchaud H, de Malartic CM, Piechon L, Wattiez A, Chapron C, Daraï E. The definition of Endometriosis Expert Centres. J Gynecol Obstet Hum Reprod. 2018 May;47(5):179-181. doi: 10.1016/j.jogoh.2018.02.003. Epub 2018 Mar 03. PMID: 29510272.
Copy Download .nbib Format: NLM
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.

Frontiers in oncology

Fumarola C, Bozza N, Castelli R, Ferlenghi F, Marseglia G, Lodola A, Bonelli M, La Monica S, Cretella D, Alfieri R, Minari R, Galetti M, Tiseo M, Ardizzoni A, Mor M, Petronini PG.
PMID: 30972293
Front Oncol. 2019 Mar 26;9:179. doi: 10.3389/fonc.2019.00179. eCollection 2019.

Fibroblast Growth Factor Receptors (FGFR1-4) have a critical role in the progression of several human cancers, including Squamous Non-Small-Cell Lung Cancer (SQCLC). Both non-selective and selective reversible FGFR inhibitors are under clinical investigation for the treatment of patients with...

Cite
Fumarola C, Bozza N, Castelli R, et al. Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. Front Oncol. 2019;9:179doi: 10.3389/fonc.2019.00179.
Fumarola, C., Bozza, N., Castelli, R., Ferlenghi, F., Marseglia, G., Lodola, A., Bonelli, M., La Monica, S., Cretella, D., Alfieri, R., Minari, R., Galetti, M., Tiseo, M., Ardizzoni, A., Mor, M., & Petronini, P. G. (2019). Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. Frontiers in oncology, 9179. https://doi.org/10.3389/fonc.2019.00179
Fumarola, Claudia, et al. "Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines." Frontiers in oncology vol. 9 (2019): 179. doi: https://doi.org/10.3389/fonc.2019.00179
Fumarola C, Bozza N, Castelli R, Ferlenghi F, Marseglia G, Lodola A, Bonelli M, La Monica S, Cretella D, Alfieri R, Minari R, Galetti M, Tiseo M, Ardizzoni A, Mor M, Petronini PG. Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. Front Oncol. 2019 Mar 26;9:179. doi: 10.3389/fonc.2019.00179. eCollection 2019. PMID: 30972293; PMCID: PMC6443895.
Copy Download .nbib Format: NLM
Treatment of Combined Hepatocellular and Cholangiocarcinoma.

Cancers

Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, Golfieri R, Spinelli D, Piscaglia F.
PMID: 32224916
Cancers (Basel). 2020 Mar 26;12(4). doi: 10.3390/cancers12040794.

Combined hepatocellular and cholangiocarcinoma (HCC-CC) is a rare primary liver cancer. It is constituted by neoplastic cells of both hepatocellular and cholangiocellular derivation. Different histology types of HCC-CC have been reported, hinting at heterogeneous carcinogenic pathways leading to the...

Cite
Leoni S, Sansone V, Lorenzo S, et al. Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers (Basel). 2020;12(4)doi: 10.3390/cancers12040794.
Leoni, S., Sansone, V., Lorenzo, S., Ielasi, L., Tovoli, F., Renzulli, M., Golfieri, R., Spinelli, D., & Piscaglia, F. (2020). Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers, 12(4), . https://doi.org/10.3390/cancers12040794
Leoni, Simona, et al. "Treatment of Combined Hepatocellular and Cholangiocarcinoma." Cancers vol. 12,4 (2020). doi: https://doi.org/10.3390/cancers12040794
Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, Golfieri R, Spinelli D, Piscaglia F. Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers (Basel). 2020 Mar 26;12(4). doi: 10.3390/cancers12040794. PMID: 32224916; PMCID: PMC7226028.
Copy Download .nbib Format: NLM
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.

Anti-cancer drugs

Brandi G, Di Federico A, Rizzo A, De Lorenzo S, Vasuri F, Brocchi S, Golfieri R, Morelli MC, Frega G, Palloni A.
PMID: 34407053
Anticancer Drugs. 2022 Jan 01;33(1):e781-e783. doi: 10.1097/CAD.0000000000001202.

The administration of approved systemic treatments for advanced hepatocellular carcinoma (HCC) is limited to patients with preserved liver function (Child-Pugh A/B7) and performance status. Conversely, metronomic chemotherapy can be safely administered to patients with poor clinical conditions and severe...

Cite
Brandi G, Di Federico A, Rizzo A, et al. The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma. Anticancer Drugs. 2022;33(1):e781-e783doi: 10.1097/CAD.0000000000001202.
Brandi, G., Di Federico, A., Rizzo, A., De Lorenzo, S., Vasuri, F., Brocchi, S., Golfieri, R., Morelli, M. C., Frega, G., & Palloni, A. (2022). The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma. Anti-cancer drugs, 33(1), e781-e783. https://doi.org/10.1097/CAD.0000000000001202
Brandi, Giovanni, et al. "The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma." Anti-cancer drugs vol. 33,1 (2022): e781-e783. doi: https://doi.org/10.1097/CAD.0000000000001202
Brandi G, Di Federico A, Rizzo A, De Lorenzo S, Vasuri F, Brocchi S, Golfieri R, Morelli MC, Frega G, Palloni A. The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma. Anticancer Drugs. 2022 Jan 01;33(1):e781-e783. doi: 10.1097/CAD.0000000000001202. PMID: 34407053.
Copy Download .nbib Format: NLM
Transcatheter embolization for giant splenic artery aneurisms: still an open question.

Case reports in radiology

Mastroroberto M, Berardi S, Renzulli M, Maggioli C, Pianta P, Pinna AD, Golfieri R, Sama C.
PMID: 22900219
Case Rep Radiol. 2012;2012:652469. doi: 10.1155/2012/652469. Epub 2012 Jul 30.

Transcatheter embolization is the mainstay of the therapy of splenic artery aneurysms (SAAs) in patients with portal hypertension. It is indicated when the SAA diameter reaches 20 mm. Although endovascular techniques are effective and safe for the treatment of...

Cite
Mastroroberto M, Berardi S, Renzulli M, et al. Transcatheter embolization for giant splenic artery aneurisms: still an open question. Case Rep Radiol. 2012;2012:652469doi: 10.1155/2012/652469.
Mastroroberto, M., Berardi, S., Renzulli, M., Maggioli, C., Pianta, P., Pinna, A. D., Golfieri, R., & Sama, C. (2012). Transcatheter embolization for giant splenic artery aneurisms: still an open question. Case reports in radiology, 2012652469. https://doi.org/10.1155/2012/652469
Mastroroberto, Marianna, et al. "Transcatheter embolization for giant splenic artery aneurisms: still an open question." Case reports in radiology vol. 2012 (2012): 652469. doi: https://doi.org/10.1155/2012/652469
Mastroroberto M, Berardi S, Renzulli M, Maggioli C, Pianta P, Pinna AD, Golfieri R, Sama C. Transcatheter embolization for giant splenic artery aneurisms: still an open question. Case Rep Radiol. 2012;2012:652469. doi: 10.1155/2012/652469. Epub 2012 Jul 30. PMID: 22900219; PMCID: PMC3414005.
Copy Download .nbib Format: NLM
The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.

La Radiologia medica

Gaudiano C, Bianchi L, De Cinque A, Corcioni B, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Golfieri R.
PMID: 34850354
Radiol Med. 2021 Nov 30; doi: 10.1007/s11547-021-01433-w. Epub 2021 Nov 30.

PURPOSE: To assess the role of the multiparametric Magnetic Resonance Imaging (mpMRI) in predicting the cribriform pattern in both the peripheral and transition zones (PZ and TZ) clinically significant prostate cancers (csPCas).MATERIAL AND METHODS: We retrospectively evaluated 150 patients...

Cite
Gaudiano C, Bianchi L, De Cinque A, et al. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors. Radiol Med. 2021;doi: 10.1007/s11547-021-01433-w.
Gaudiano, C., Bianchi, L., De Cinque, A., Corcioni, B., Giunchi, F., Schiavina, R., Fiorentino, M., Brunocilla, E., & Golfieri, R. (2021). The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors. La Radiologia medica, . https://doi.org/10.1007/s11547-021-01433-w
Gaudiano, Caterina, et al. "The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors." La Radiologia medica vol. (2021). doi: https://doi.org/10.1007/s11547-021-01433-w
Gaudiano C, Bianchi L, De Cinque A, Corcioni B, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Golfieri R. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors. Radiol Med. 2021 Nov 30; doi: 10.1007/s11547-021-01433-w. Epub 2021 Nov 30. PMID: 34850354.
Copy Download .nbib Format: NLM
Major trauma with only dynamic criteria: is the routine use of whole-body CT as a first level examination justified?.

La Radiologia medica

Mulas V, Catalano L, Geatti V, Alinari B, Ragusa F, Golfieri R, Orlandi PE, Imbriani M.
PMID: 34843028
Radiol Med. 2021 Nov 29; doi: 10.1007/s11547-021-01430-z. Epub 2021 Nov 29.

PURPOSE: Risks and benefits of systematic use of whole-body CT (WBCT) in patients with major trauma when no injury is clinically suspected is still subject of controversy. WBCT allows early identification of potentially evolving lesions, but exposes patients to...

Cite
Mulas V, Catalano L, Geatti V, et al. Major trauma with only dynamic criteria: is the routine use of whole-body CT as a first level examination justified?. Radiol Med. 2021;doi: 10.1007/s11547-021-01430-z.
Mulas, V., Catalano, L., Geatti, V., Alinari, B., Ragusa, F., Golfieri, R., Orlandi, P. E., & Imbriani, M. (2021). Major trauma with only dynamic criteria: is the routine use of whole-body CT as a first level examination justified?. La Radiologia medica, . https://doi.org/10.1007/s11547-021-01430-z
Mulas, Violante, et al. "Major trauma with only dynamic criteria: is the routine use of whole-body CT as a first level examination justified?." La Radiologia medica vol. (2021). doi: https://doi.org/10.1007/s11547-021-01430-z
Mulas V, Catalano L, Geatti V, Alinari B, Ragusa F, Golfieri R, Orlandi PE, Imbriani M. Major trauma with only dynamic criteria: is the routine use of whole-body CT as a first level examination justified?. Radiol Med. 2021 Nov 29; doi: 10.1007/s11547-021-01430-z. Epub 2021 Nov 29. PMID: 34843028.
Copy Download .nbib Format: NLM
A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection.

SA journal of radiology

Brandi N, Bartalena L, Mosconi C, Golfieri R.
PMID: 34230863
SA J Radiol. 2021 Jun 17;25(1):2122. doi: 10.4102/sajr.v25i1.2122. eCollection 2021.

Intravesical instillation of Bacillus Calmette-Guérin (BCG) is used as an adjuvant treatment of bladder cancer. Systemic BCG infection occurs in less than 1% of cases, and pulmonary involvement is even rarer (0.3% - 0.7%), with a favourable prognosis. A...

Cite
Brandi N, Bartalena L, Mosconi C, et al. A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection. SA J Radiol. 2021;25(1):2122doi: 10.4102/sajr.v25i1.2122.
Brandi, N., Bartalena, L., Mosconi, C., & Golfieri, R. (2021). A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection. SA journal of radiology, 25(1), 2122. https://doi.org/10.4102/sajr.v25i1.2122
Brandi, Nicolò, et al. "A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection." SA journal of radiology vol. 25,1 (2021): 2122. doi: https://doi.org/10.4102/sajr.v25i1.2122
Brandi N, Bartalena L, Mosconi C, Golfieri R. A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection. SA J Radiol. 2021 Jun 17;25(1):2122. doi: 10.4102/sajr.v25i1.2122. eCollection 2021. PMID: 34230863; PMCID: PMC8252158.
Copy Download .nbib Format: NLM
Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding.

Minerva gastroenterology

Brandi N, Parmeggiani A, Brocchi S, Balacchi C, Gaudiano C, Golfieri R.
PMID: 32623867
Minerva Gastroenterol (Torino). 2021 Jun;67(2):211-213. doi: 10.23736/S2724-5985.20.02715-4. Epub 2020 Jul 03.

No abstract available.

Cite
Brandi N, Parmeggiani A, Brocchi S, et al. Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding. Minerva Gastroenterol (Torino). 2020;67(2):211-213doi: 10.23736/S2724-5985.20.02715-4.
Brandi, N., Parmeggiani, A., Brocchi, S., Balacchi, C., Gaudiano, C., & Golfieri, R. (2021). Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding. Minerva gastroenterology, 67(2), 211-213. https://doi.org/10.23736/S2724-5985.20.02715-4
Brandi, Nicolò, et al. "Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding." Minerva gastroenterology vol. 67,2 (2021): 211-213. doi: https://doi.org/10.23736/S2724-5985.20.02715-4
Brandi N, Parmeggiani A, Brocchi S, Balacchi C, Gaudiano C, Golfieri R. Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding. Minerva Gastroenterol (Torino). 2021 Jun;67(2):211-213. doi: 10.23736/S2724-5985.20.02715-4. Epub 2020 Jul 03. PMID: 32623867.
Copy Download .nbib Format: NLM
Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching.

Liver cancer

Golfieri R, Bezzi M, Verset G, Fucilli F, Mosconi C, Cappelli A, Paccapelo A, Lucatelli P, Magand N, Rode A, De Baere T.
PMID: 34721513
Liver Cancer. 2021 Jul 14;10(5):522-534. doi: 10.1159/000516613. eCollection 2021 Sep.

INTRODUCTION: The aim of this multicenter comparison of balloon-occluded transarterial chemoembolization (B-TACE) versus conventional TACE (cTACE) in treating hepatocellular carcinoma (HCC) was to assess in which size range the 2 techniques offered higher complete response (CR) and objective response...

Cite
Golfieri R, Bezzi M, Verset G, et al. Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching. Liver Cancer. 2021;10(5):522-534doi: 10.1159/000516613.
Golfieri, R., Bezzi, M., Verset, G., Fucilli, F., Mosconi, C., Cappelli, A., Paccapelo, A., Lucatelli, P., Magand, N., Rode, A., & De Baere, T. (2021). Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching. Liver cancer, 10(5), 522-534. https://doi.org/10.1159/000516613
Golfieri, Rita, et al. "Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching." Liver cancer vol. 10,5 (2021): 522-534. doi: https://doi.org/10.1159/000516613
Golfieri R, Bezzi M, Verset G, Fucilli F, Mosconi C, Cappelli A, Paccapelo A, Lucatelli P, Magand N, Rode A, De Baere T. Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching. Liver Cancer. 2021 Jul 14;10(5):522-534. doi: 10.1159/000516613. eCollection 2021 Sep. PMID: 34721513; PMCID: PMC8529335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 158 entries